Anika Therapeutics, Inc. (ANIK) stock
ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$12.85−0.07 (-0.54%)
Close on Nov 17, 2026Market cap $171.97MP/E –Yield –
Anika Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Anika Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was -3.1%. For fiscal 2025 it was -9.6%, against -47.0% the year before. The highest annual figure on record is 36.3% in fiscal 2014.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -9.6% | +37.4 |
| FY2024 | Dec 31, 2024 | -47.0% | +21.4 |
| FY2023 | Dec 31, 2023 | -68.4% | −55.4 |
| FY2022 | Dec 31, 2022 | -13.1% | −15.9 |
| FY2021 | Dec 31, 2021 | 2.8% | +21.2 |
| FY2020 | Dec 31, 2020 | -18.4% | −42.1 |
| FY2019 | Dec 31, 2019 | 23.7% | +6.0 |
| FY2018 | Dec 31, 2018 | 17.7% | −10.3 |
| FY2017 | Dec 31, 2017 | 28.1% | −3.4 |
| FY2016 | Dec 31, 2016 | 31.5% | −1.6 |
| FY2015 | Dec 31, 2015 | 33.1% | −3.2 |
| FY2014 | Dec 31, 2014 | 36.3% | +8.9 |
| FY2013 | Dec 31, 2013 | 27.4% | +10.9 |
| FY2012 | Dec 31, 2012 | 16.5% | +3.4 |
| FY2011 | Dec 31, 2011 | 13.1% | +5.3 |
| FY2010 | Dec 31, 2010 | 7.8% | −1.4 |
| FY2009 | Dec 31, 2009 | 9.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 10.1% | +24.2 |
| Q1 FY2026 | Mar 31, 2026 | -17.1% | +1.5 |
| Q4 FY2025 | Dec 31, 2025 | 1.0% | +72.4 |
| Q3 FY2025 | Sep 30, 2025 | -8.4% | +92.8 |
| Q2 FY2025 | Jun 30, 2025 | -14.1% | −13.8 |
| Q1 FY2025 | Mar 31, 2025 | -18.6% | −3.1 |
| Q4 FY2024 | Dec 31, 2024 | -71.4% | +75.2 |
| Q3 FY2024 | Sep 30, 2024 | -101.2% | −85.4 |
| Q2 FY2024 | Jun 30, 2024 | -0.3% | +5.9 |
| Q1 FY2024 | Mar 31, 2024 | -15.6% | +11.7 |
| Q4 FY2023 | Dec 31, 2023 | -146.6% | −134.2 |
| Q3 FY2023 | Sep 30, 2023 | -15.9% | −5.5 |
| Q2 FY2023 | Jun 30, 2023 | -6.2% | +1.0 |
| Q1 FY2023 | Mar 31, 2023 | -27.3% | −19.3 |
| Q4 FY2022 | Dec 31, 2022 | -12.4% | +3.8 |
| Q3 FY2022 | Sep 30, 2022 | -10.4% | −11.8 |
| Q2 FY2022 | Jun 30, 2022 | -7.2% | −24.3 |
| Q1 FY2022 | Mar 31, 2022 | -8.0% | −16.3 |
| Q4 FY2021 | Dec 31, 2021 | -16.2% | +31.7 |
| Q3 FY2021 | Sep 30, 2021 | 1.4% | +21.6 |
| Q2 FY2021 | Jun 30, 2021 | 17.1% | +42.2 |
| Q1 FY2021 | Mar 31, 2021 | 8.3% | −8.1 |
| Q4 FY2020 | Dec 31, 2020 | -47.9% | −61.5 |
| Q3 FY2020 | Sep 30, 2020 | -20.2% | −51.2 |
| Q2 FY2020 | Jun 30, 2020 | -25.1% | −56.1 |
| Q1 FY2020 | Mar 31, 2020 | 16.4% | −1.9 |
| Q4 FY2019 | Dec 31, 2019 | 13.6% | −15.0 |
| Q3 FY2019 | Sep 30, 2019 | 31.0% | +2.6 |
| Q2 FY2019 | Jun 30, 2019 | 31.0% | −2.0 |
| Q1 FY2019 | Mar 31, 2019 | 18.2% | +49.7 |
| Q4 FY2018 | Dec 31, 2018 | 28.6% | +1.2 |
| Q3 FY2018 | Sep 30, 2018 | 28.4% | +3.0 |
| Q2 FY2018 | Jun 30, 2018 | 33.0% | −0.9 |
| Q1 FY2018 | Mar 31, 2018 | -31.4% | −54.9 |
| Q4 FY2017 | Dec 31, 2017 | 27.4% | −0.7 |
| Q3 FY2017 | Sep 30, 2017 | 25.3% | −9.4 |
| Q2 FY2017 | Jun 30, 2017 | 34.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 23.5% | – |
| Q4 FY2016 | Dec 31, 2016 | 28.1% | – |
| Q3 FY2016 | Sep 30, 2016 | 34.7% | – |
See a number that looks wrong?